[PMID: 6732844] PubMed record related to this compound for laboratory literature review
BPC-157 has no FDA-approved human therapeutic application, and published human pharmacokinetic data for this exact finished product and dose could not be verified in the peer-reviewed literature reviewed for this article
Reference ranges may vary between laboratories
Its enhanced stability and resistance to enzymatic degradation make it a preferred research tool for investigating GH-related physiology and GH-independent mechanisms 1
Thymosin beta-4 peptides have been examined for their effects on inflammatory signaling networks and cellular survival pathways, with studies describing modulation of endothelial behavior, oxidative stress responses, and reparative cell activity in experimental models [7][8]
However, in a subanalysis of participants with low vitamin B 12 status at baseline (n= 101), the B-vitamin supplementation slowed the decline in bone mineral density (total hip and femoral neck but not lumbar spine) (116)